FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Medical Device Security Moving in Right Direction: Article

A Healthcare IT News analysis says the medical device industry and FDA are moving in the right direction to improve medical device security.

Human Drugs

FDA Planning Microbiome Product Conference

FDA commissioner Scott Gottlieb announces a 9/17 workshop on microbiome-based products and their use in preventing, treating, and curing diseases in h...

Human Drugs

Drug User Fee Program Fee Invoices Mailed

CDER says FY 2019 User Fee Program Fee invoices were emailed 8/15 with a 10/1 due date for the $309,915 fee.

FDA General

Improper Influence on FDA Science, Survey Says

A Center for Science and Democracy survey of FDA scientists praises agency leaders while raising some concerns about political and industry interferen...

Human Drugs

Evoke Pharma NDA for Diabetic Gastroparesis Therapy

FDA accepts for review an Evoke Pharma 505(b)(2) NDA for Gimoti, a nasal spray product candidate for relieving symptoms in adult women with acute and ...

Human Drugs

Sun Pharma Tear Production Drug Approved

FDA approves Sun Pharmaceutical Industries Cequa (cyclosporine ophthalmic solution) 0.09%, indicated to increase tear production in patients with kera...

Human Drugs

Endo Drug Compounding Suit Moving Forward

Endo resumes its suit challenging FDAs interim policy on drug compounding and seeking removal of vasopressin from Category 1 nominations for bulk comp...

Human Drugs

FDA Approves Eisai and Mercks Lenvima

FDA approves Eisai and Mercks kinase inhibitor Lenvima (lenvatinib) for the first-line treatment of patients with unresectable hepatocellular carcinom...

Human Drugs

Changes Sought in LPAD Draft Guidance

Two pharmaceutical trade associations suggest changes to a draft antibiotic limited population pathway guidance.

Federal Register

Priority Preview Voucher Granted to Ultragenyx

Federal Register notice: FDA issued a priority review voucher to Ultragenyx Pharmaceutical for its approved rare pediatric disease product application...